Synexus Clinical Research US, Inc
Anderson, South Carolina, United States
Doctor in Anderson, South Carolina
1657 E Greenville St, Anderson, SC 29621
About Synexus Clinical Research US, Inc
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Allergan
5
Janssen Research & Development, LLC
3
Pfizer
3
Celgene
2
Janssen Vaccines & Prevention B.V.
2
Phathom Pharmaceuticals, Inc.
2
Bavarian Nordic
1
Bellus Health Inc
1
Boston Pharmaceuticals
1
Emergent BioSolutions
1
Evelo Biosciences, Inc.
1
Clinical Trials at Synexus Clinical Research US, Inc
During the past decade, Synexus Clinical Research US, Inc conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 14 clinical trials were completed, i.e. on
average, 56% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 14 clinical trials were completed. i.e. 155.6%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
2017-03-23
2022-07-27
Terminated
10,544
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis 01
2017-09-29
2020-07-08
Terminated
336
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
2018-02-01
2020-11-05
Terminated
450
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03
2018-01-24
2020-10-30
Terminated
467
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
2018-03-08
2025-06-30
Active, not recruiting
3,163
Study to Evaluate the Safety and Efficacy of Relamorelin in Participants With Diabetic Gastroparesis Study 02
2018-02-16
2020-07-16
Terminated
311
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
2018-04-13
2030-06-30
Active, not recruiting
1,409
Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
2018-10-29
2020-03-06
Completed
838
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Synexus Clinical Research US, Inc" #1 sponsor was "Allergan" with 5 trials, followed by "Janssen Research & Development, LLC" with 3 trials
sponsored, "Pfizer" with 3 trials sponsored, "Celgene" with 2 trials sponsored and "Janssen Vaccines & Prevention B.V."
with 2 trials sponsored. Other sponsors include 5 different institutions and
companies that sponsored additional 14 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Synexus Clinical Research US, Inc"
#1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Synexus Clinical Research US, Inc
According to Clinical.Site data, the most researched conditions in "Synexus Clinical Research US, Inc" are
"Diabetes Mellitus" (4 trials), "Gastroparesis" (4 trials), "Atopic Dermatitis" (2 trials), "Dermatitis, Atopic" (2 trials) and "Eosinophilic Esophagitis" (2 trials). Many other conditions were trialed in "Synexus Clinical Research US, Inc" in a lesser frequency.
Clinical Trials Intervention Types at Synexus Clinical Research US, Inc
Most popular intervention types in "Synexus Clinical Research US, Inc" are "Drug" (21 trials), "Biological" (4 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (19 trials), "Relamorelin" (4 trials), "CC-93538" (2 trials), "Guselkumab" (2 trials) and "Guselkumab Dose 1" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Synexus Clinical Research US, Inc
The vast majority of trials in "Synexus Clinical Research US, Inc" are
24 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Synexus Clinical Research US, Inc
Currently, there are NaN active trials in "Synexus Clinical Research US, Inc".
undefined are not yet recruiting,
4 are recruiting,
5 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 11 completed trials in Synexus Clinical Research US, Inc,
undefined suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Synexus Clinical Research US, Inc, 0 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 21 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".